Regulatory role of cytosolic phospholipase A2α in NADPH oxidase activity and in inducible nitric oxide synthase induction by aggregated Aβ1-42 in microglia

GLIA

Volumn 57, Issue 16, 2009, Pages 1727-1740

  Szaingurten Solodkin, I ^a   Hadad, N ^a   Levy, Rachel ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Microglia; NADPH oxidase; Phospholipase A2

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; ANTISENSE OLIGONUCLEOTIDE; CD68 ANTIGEN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOOXYGENASE 2; CYTOSOLIC PHOSPHOLIPASE A2; CYTOSOLIC PHOSPHOLIPASE A2 ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; PROSTAGLANDIN E2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SERINE; SUPEROXIDE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SYNTHESIS; IMMUNOFLUORESCENCE; INFLAMMATION; MICROGLIA; NEUROPATHOLOGY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION;

AMYLOID BETA-PROTEIN; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BLOTTING, WESTERN; CELLS, CULTURED; CYTOSOL; DINOPROSTONE; FLUORESCENT ANTIBODY TECHNIQUE; GROUP IV PHOSPHOLIPASES A2; IMMUNOPRECIPITATION; INFLAMMATION; MICROGLIA; MICROSCOPY, CONFOCAL; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 71249160483     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20886     Document Type: Article

References (66)

1. Abe M, Kitsuki H, Saruwatari S, Asoh H, Sakurada T, Kuwata H, Nakatani Y, Kudo I, Furukawa T. 1997. Cancer cells isolated from malignant pleural and peritoneal effusions inhibit phospholipase A2 activity in human polymorphonuclear leukocytes. Cancer Lett 121: 155-161. (Pubitemid 28008914)
2. Babior BM. 1999. NADPH oxidase: An update. Blood 93:1464-1476.
3. Bae YS, Kim Y, Kim JH, Lee TG, Suh PG, Ryu SH. 2000. Independent functioning of cytosolic phospholipase A2 and phospholipase D1 in Trp-Lys-Tyr-Met-Val-D-Met-induced superoxide generation in human monocytes. J Immunol 164:4089-4096. (Pubitemid 30215064)
4. Bal-Price A, Matthias A, Brown GC. 2002. Stimulation of the NADPH oxidase in activated rat microglia removes nitric oxide but induces peroxynitrite production. J Neurochem 80:73-80. (Pubitemid 34614579)
5. Barnham KJ, Masters CL, Bush AI. 2004. Neurodegenerative diseases and oxidative stress. Nat Rev Drug Discov 3:205-214.
6. Bianca VD, Dusi S, Bianchini E, Dal Pra I, Rossi F. 1999. Beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem 274:15493-15499.
7. Brown DR. 2001. Microglia and prion disease. Microsc Res Tech 54: 71-80.
8. Citron M. 2002a. Alzheimer's disease: Treatments in discovery and development. Nat Neurosci 5(Suppl):1055-1057. (Pubitemid 35247198)
9. Citron M. 2002b. Emerging Alzheimer's disease therapies: Inhibition of beta-secretase. Neurobiol Aging 23:1017-1022. (Pubitemid 35447782)
10. Clemens JA, Stephenson DT, Smalstig EB, Roberts EF, Johnstone EM, Sharp JD, Little SP, Kramer RM. 1996. Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat. Stroke 27:527-535.
11. Colangelo VSJ, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ. 2002. Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70:462-473.
12. Combs CK, Karlo JC, Kao SC, Landreth GE. 2001. Beta-amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci 21:1179-1188.
13. Cotman C. 1996. Mechanisms of neuronal death in Alzheimer's disease. Brain Pathol 6:493-506. (Pubitemid 26388719)
14. Dana R, Leto TL, Malech HL, Levy R. 1998. Essential requirement of cytosolic phospholipase A2 for activation of the phagocyte NADPH oxidase. J Biol Chem 273:441-445. (Pubitemid 28042230)
15. Dana R, Malech HL, Levy R. 1994. The requirement for phospholipase A2 for activation of the assembled NADPH oxidase in human neutrophils. Biochem J 297:217-223.
16. de la Monte SM, Wands JR. 2006. Molecular indices of oxidative stress and mitochondrial dysfunction occur early and often progress with severity of Alzheimer's disease. J Alzheimers Dis 9:167-181.
17. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. 1993. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83.
18. Gijon MA, Spencer DM, Siddiqi AR, Bonventre JV, Leslie CC. 2000. Cytosolic phospholipase A2 is required for macrophage arachidonic acid release by agonists that do and do not mobilize calcium. Novel role of mitogen-activated protein kinase pathways in cytosolic phospholipase A2 regulation. J Biol Chem 275:20146-20156.
19. Girotti M, Evans JH, Burke D, Leslie CC. 2004. Cytosolic phospholipase A2 translocates to forming phagosomes during phagocytosis of zymosan in macrophages. J Biol Chem 279:19113-19121. (Pubitemid 38623342)
20. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. 1982. Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 126:131-138. (Pubitemid 13203451)
21. Grinshpun J, Tveria L, Fleisher-Berkovich S. 2008. Differential regulation of prostaglandin synthesis in neonatal rat microglia and astrocytes by somatostatin. Eur J Pharmacol 19:19.
22. Guzik TJ, Korbut R, Adamek-Guzik T. 2003. Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54: 469-487. (Pubitemid 38029745)
23. Haass C, Selkoe DJ. 2007. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101-112. (Pubitemid 46432529)
24. Hazan I, Dana R, Granot Y, Levy R. 1997. Cytosolic phospholipase A2 and its mode of activation in human neutrophils by opsonized zymosan. Correlation between 42/44 kDa mitogen-activated protein kinase, cytosolic phospholipase A2 and NADPH oxidase. Biochem J 326:867-876.
25. Hazan-Eitan Z, Weinstein Y, Hadad N, Konforty A, Levy R. 2006. Induction of Fc gammaRIIA expression in myeloid PLB cells during differentiation depends on cytosolic phospholipase A2 activity and is regulated via activation of CREB by PGE2. Blood 108:1758-1766. (Pubitemid 44316147)
26. Iwahashi H, Takeshita A, Hanazawa S. 2000. Prostaglandin E2 stimulates AP-1-mediated CD14 expression in mouse macrophages via cyclic AMP-dependent protein kinase A. J Immunol 164:5403-5408. (Pubitemid 30305222)
27. Jamaluddin M, Wang S, Boldogh I, Tian B, Brasier AR. 2007. TNF-alpha- induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. Cell Signal 19:1419-1433. (Pubitemid 46818908)
28. Jeohn GH, Kong LY, Wilson B, Hudson P, Hong JS. 1998. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 85:1-10. (Pubitemid 28255432)
29. Kim C, Dinauer MC. 2006. Impaired NADPH oxidase activity in Rac2- deficient murine neutrophils does not result from defective translocation of p47phox and p67phox and can be rescued by exogenous arachidonic acid. J Leukoc Biol 79:223-234. (Pubitemid 43054268)
30. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
31. Lal MA. 2002. Role of oxidative stress in advanced glycation end product- induced mesangial cell activation. Kidney Int 61:2006-2014.
32. Leto TL, Garrett MC, Fujii H, Nunoi H. 1991. Characterization of neutrophil NADPH oxidase factors p47-phox and p67-phox from recombinant baculoviruses. J Biol Chem 266:19812-19818. (Pubitemid 21908299)
33. Li J, Baud O, Vartanian T, Volpe JJ, Rosenberg PA. 2005. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci USA 102:9936-9941. (Pubitemid 40993671)
34. Liberty IF, Raichel L, Hazan-Eitan Z, Pessach I, Hadad N, Schlaeffer F, Levy R. 2004. Cytosolic phospholipase A2 is responsible for prostaglandin E2 and leukotriene B4 formation in phagocyte-like PLB-985 cells: Studies of differentiated cPLA2-deficient PLB-985 cells. J Leukoc Biol 76:176-184. (Pubitemid 38857185)
35. McGeer P. 1995. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21:195-218. (Pubitemid 26061873)
36. Mendes AF, Carvalho AP, Caramona MM, Lopes MC. 2001. Diphenyleneiodonium inhibits NF-kappaB activation and iNOS expression induced by IL-1beta: Involvement of reactive oxygen species. Mediators Inflamm 10:209-215.
37. Minghetti L, Nicolini A, Polazzi E, Creminon C, Maclouf J, Levi G. 1997. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia 19:152-160. (Pubitemid 27094132)
38. Moore STS. 1996. The concept of microglia in relation to central nervous system disease and regeneration. Prog Neurobiol 48:441-460. (Pubitemid 26189424)
39. Neumann J. 2008. Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: A new mechanism of CNS immune privilege. J Neurosci 28:5965-5975.
40. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA. 2001. Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60:759-767. (Pubitemid 32678256)
41. O'Dowd YM, El-Benna J, Perianin A, Newsholme P. 2004. Inhibition of formyl-methionyl-leucyl-phenylalanine-stimulated respiratory burst in human neutrophils by adrenaline: Inhibition of phospholipase A2 activity but not p47phox phosphorylation and translocation. Biochem Pharmacol 67:183-190. (Pubitemid 37518546)
42. Pahan K, Sheikh FG, Namboodiri AM, Singh I. 1998. N-acetyl cysteine inhibits induction of no production by endotoxin or cytokine stimulated rat peritoneal macrophages, C6 glial cells and astrocytes. Free Radic Biol Med 24:39-48. (Pubitemid 28006434)
43. Pannu R, Won JS, Khan M, Singh AK, Singh I. 2004. A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma- mediated inducible nitric oxide synthase gene expression: Implications for neuroinflammatory diseases. J Neurosci 24:5942-5954. (Pubitemid 38859392)
44. Pantano C, Reynaert NL, van der Vliet A, Janssen-Heininger YM. 2006. Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal 8:1791-1806. (Pubitemid 44726352)
45. Pawate S, Shen Q, Fan F, Bhat NR. 2004. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J Neurosci Res 77:540-551. (Pubitemid 39007006)
46. Phillis JW, Horrocks LA, Farooqui AA. 2006. Cyclooxygenases, lipoxy-genases, and epoxygenases in CNS: Their role and involvement in neurological disorders. Brain Res Rev 52:201-243.
47. Raichel L, Berger S, Hadad N, Kachko L, Karter M, Szaingurten-Solodkin I, Williams R, Feldmann M, Levy R. 2008. Reduction of cPLA(2alpha) overexpression: An efficient anti-inflammatory therapy for collagen-induced arthritis. Eur J Immunol 38:2905-2915.
48. Raine CS. 1994. Multiple sclerosis: Immune system molecule expression in the central nervous system. J Neuropathol Exp Neurol 53:328-337. (Pubitemid 24216030)
49. Rogers JSR, Kovelowski CJ, Li R. 2002. Microglia and inflammatory mechanisms in the clearance of amyloid beta peptide. Glia 40:260-269. (Pubitemid 35337383)
50. Rosenberger J. 2001. Oxidative stress induces proorphanin FQ, proenkephalin gene expression in astrocytes through p38- and ERK-MAP kinases and NF-kappaB. J Neurochem 79:35-44. (Pubitemid 32946640)
51. Rubin BB, Downey GP, Koh A, Degousee N, Ghomashchi F, Nallan L, Stefanski E, Harkin DW, Sun C, Smart BP, Lindsay TF, Cherepanov V, Vachon E, Kelvin D, Sadilek M, Brown GE, Yaffe MB, Plumb J, Grinstein S, Glogauer M, Gelb MH. 2005. Cytosolic phospholipase A2-alpha is necessary for platelet-activating factor biosynthesis, efficient neutrophil-mediated bacterial killing, and the innate immune response to pulmonary infection: cPLA2-alpha does not regulate neutrophil NADPH oxidase activity. J Biol Chem 280: 7519-7529.
52. Saha RN, Pahan K. 2006. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 8:929-947. (Pubitemid 44036510)
53. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D, Boyd MR. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res 48:4827-4833. (Pubitemid 18224442)
54. Shaywitz AJ. 1999. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68:821-861.
55. Shmelzer Z, Haddad N, Admon E, Pessach I, Leto TL, Eitan-Hazan Z, Hershfinkel M, Levy R. 2003. Unique targeting of cytosolic phospholipase A2 to plasma membranes mediated by the NADPH oxidase in phagocytes. J Cell Biol 162:683-692. (Pubitemid 37022945)
56. Shmelzer Z, Karter M, Eisenstein M, Leto TL, Hadad N, Ben-Menahem D, Gitler D, Banani S, Wolach B, Rotem M, Levy R. 2008. Cystosolic phospholipase A2alpha is targeted to P47phox-PX domain of the assembled NADPH oxidase via a novel binding site in its C2 domain. J Biol Chem 283:31898-31908.
57. Stahelin RV, Rafter JD, Das S, Cho W. 2003. The molecular basis of differential subcellular localization of C2 domains of protein kinase Calpha and group IVa cytosolic phospholipase A2. J Biol Chem 278: 12452-12460. (Pubitemid 36800232)
58. Stephenson D, Rash K, Smalstig B, Roberts E, Johnstone E, Sharp J, Panetta J, Little S, Kramer R, Clemens J. 1999. Cytosolic phospholipase A2 is induced in reactive glia following different forms of neuro-degeneration. Glia 27:110-128. (Pubitemid 29365748)
59. Stephenson DT, Lemere CA, Selkoe DJ, Clemens JA. 1996. Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain. Neurobiol Dis 3:51-63. (Pubitemid 26145405)
60. Stuehr DJ, Fasehun OA, Kwon NS, Gross SS, Gonzalez JA, Levi R, Nathan CF. 1991. Inhibition of macrophage and endothelial cell nitric oxide synthase by diphenyleneiodonium and its analogs. FASEB J 5: 98-103. (Pubitemid 21892842)
61. Won JS, Im YB, Khan M, Singh AK, Singh I. 2005. Involvement of phospholipase A2 and lipoxygenase in lipopolysaccharide-induced inducible nitric oxide synthase expression in glial cells. Glia 51:13-21. (Pubitemid 41059154)
62. Yu JH, Lim JW, Kim KH, Morio T, Kim H. 2005. NADPH oxidase and apoptosis in cerulein-stimulated pancreatic acinar AR42J cells. Free Radic Biol Med 39:590-602. (Pubitemid 41112101)
63. Zhao X, Bey EA, Wientjes FB, Cathcart MK. 2002. Cytosolic phospholipase A2 (cPLA2) regulation of human monocyte NADPH oxidase activity. cPLA2 affects translocation but not phosphorylation of p67(phox) and p47(phox). J Biol Chem 277:25385-25392.
64. Zhong H. 1997. The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89:413-424. (Pubitemid 27220886)
65. Zhou M, Diwu Z, Panchuk-Voloshina N, Haugland RP. 1997. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: Applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal Biochem 253: 162-168. (Pubitemid 27508167)
66. Zhu D, Lai Y, Shelat PB, Hu C, Sun GY, Lee JC. 2006. Phospholipases A2 mediate amyloid-beta peptide-induced mitochondrial dysfunction. J Neurosci 26:11111-11119. (Pubitemid 44772199)